MTOR and lymphangioleiomyomatosis: The function loss of the TSC2 gene leads to aberrant mTOR pathway activation and multiple tumors including subependymal giant cell astrocytomas, angiomyolipomas, lymphangioleiomyomatosis, and angiofibromas (Henske et al., 2016).